Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...

An upbeat tone is seeping into markets as investors dig into Nvidia's quarterly earnings beat, which signaled plenty of scope ...

Moderna’s reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...